L94.3

Clinical Causes: Autoimmune reactions in systemic sclerosis (scleroderma) Genetic predisposition to connective tissue disorders Environmental factors such as exposure to silica dust or certain chemicals Vascular abnormalities leading to skin fibrosis Secondary to other connective tissue diseases like rheumatoid arthritis or lupus

Key Symptoms: Thickened, tight skin on the fingers and toes Reduced flexibility and movement of the affected digits Swelling or puffiness in the fingers Deformities such as tapering of the fingers Skin appearing shiny and stretched Potential pain or discomfort in the affected areas Loss of normal finger or toe contours

Diagnosis Path: Diagnosis involves a clinical examination noting skin changes and deformities, along with imaging studies to assess tissue and joint involvement. Blood tests may reveal specific autoantibodies associated with systemic sclerosis. Sometimes, skin biopsies are performed to confirm fibrosis. Imaging like X-rays can help evaluate joint and bone involvement. Early detection is essential for managing associated complications and slowing disease progression.

Treatment Protocols: While there is no cure for sclerodactyly itself, treatment aims to manage symptoms and prevent complications. Approaches include: - Medications to improve blood flow and reduce fibrosis, such as calcium channel blockers - Physical therapy to maintain joint flexibility and function - Skin moisturizers and care to manage dryness and tightness - Immunosuppressive drugs in cases linked to systemic sclerosis - Preventative measures against Raynaud's phenomenon, which often accompanies sclerodactyly - Regular monitoring of internal organ health for related systemic involvement Treatment plans are tailored to each individual based on the severity and progression of the disease.